Company / EPS (Diluted)
GoodRx Holdings, Inc. EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$0.02
FY2025
5-year range
-$1.07 / $0.18
FY2021-FY2025
Trend
+75.0%
vs FY2024
Sector context
#190 of 326
Information Technology
What the data says
At $-0.02, GoodRx Holdings, Inc.'s eps (diluted) ranks #190 of 326 in the Information Technology sector. EPS (Diluted) has fluctuated over the past 8 years, ranging from $-1.07 in FY2022 to $0.18 in FY2021.
Based on SEC 10-K filings.
-0.02 in FY2025.
Improved from $-0.06 to $-0.02 over the past 2 years.
Information Technology sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#190 of 326 in Information TechnologyTop 58% of 326This company -$0.02 Sector average $1.09
▼
-101.8% below sector average
Key checks
Key Insights
- In FY2025, eps (diluted) increased 75.0% year-over-year.
- Ranks #190 out of 326 companies in the Information Technology sector.
- Peak eps (diluted) was recorded in FY2021.
- Lowest eps (diluted) in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.02 | +75.0% |
| FY2024 | -$0.08 | -33.3% |
| FY2023 | -$0.06 | +94.4% |
| FY2022 | -$1.07 | -694.4% |
| FY2021 | $0.18 | +50.0% |
| FY2020 | $0.12 | -33.3% |
| FY2019 | $0.18 | +50.0% |
| FY2018 | $0.12 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026